Abstract
Although nintedanib is overwhelmingly prescribed to elderly patients, this is the first study to demonstrate that ageing does not impact the efficacy of nintedanib. This study sheds light on the utility of aged animal models in pulmonary fibrosis. https://bit.ly/3zA9RC5
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Aging
-
Humans
-
Idiopathic Pulmonary Fibrosis* / drug therapy
-
Indoles* / therapeutic use
-
Protein Kinase Inhibitors
Substances
-
Indoles
-
Protein Kinase Inhibitors
-
nintedanib